Table 3.
Example reference regimen (DA EPOCH-R) codified and aligned to the reference library database for dose level 1*
| Row | INN of drug | Dose quantity | Dose unit | Route of admin | Cycle numbers | Cycle durations (days) | Cycle admin day numbers | Cycle admin frequency per day |
| 1 | Prednisolone | 60 | mg/m2 | Oral | 1,2,3,4,5,6 | 21,21,21,21,21,21 | 1–5,1–5,1–5,1–5,1–5,1–5 | 2,2,2,2,2,2 |
| 2 | Rituximab | 375 | mg/m2 | Intravenous | 1,2,3,4,5,6 | 21,21,21,21,21,21 | 1,1,1,1,1,1 | 1,1,1,1,1,1 |
| 3 | Doxorubicin | 10 | mg/m2 | Continuous Intravenous | 1,2,3,4,5,6 | 21,21,21,21,21,21 | 1–4,1–4,1–4,1–4,1–4,1–4 | 1,1,1,1,1,1 |
| 4 | Vincristine | 0,4 | mg/m2 | Continuous Intravenous | 1,2,3,4,5,6 | 21,21,21,21,21,21 | 1–4,1–4,1–4,1–4,1–4,1–4 | 1,1,1,1,1,1 |
| 5 | Etoposide | 50 | mg/m2 | Continuous Intravenous | 1,2,3,4,5,6 | 21,21,21,21,21,21 | 1–4,1-4,1–4,1-4,1–4,1-4 | 1,1,1,1,1,1 |
| 6 | Cyclophosphamide | 750 | mg/m2 | Intravenous | 1,2,3,4,5,6 | 21,21,21,21,21,21 | 5,5,5,5,5,5 | 1,1,1,1,1,1 |
*Subsequent cycles will be recognisable in a clinical anonymised database, based on the fact that each patient starts at dose level 1.
INN, International non-proprietary name.